These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1903771)
21. Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Orme IM; Henao-Tamayo MI Front Immunol; 2018; 9():461. PubMed ID: 29568298 [TBL] [Abstract][Full Text] [Related]
22. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518 [TBL] [Abstract][Full Text] [Related]
23. The relative difference in anti-Listeria resistance of C57BL/6 and A/J mice is not eliminated by active immunization or by transfer of Listeria-immune T cells. Czuprynski CJ; Brown JF Immunology; 1986 Jul; 58(3):437-43. PubMed ID: 3488261 [TBL] [Abstract][Full Text] [Related]
24. Coadministration of interleukins 7 and 15 with bacille Calmette-Guérin mounts enduring T cell memory response against Mycobacterium tuberculosis. Singh V; Gowthaman U; Jain S; Parihar P; Banskar S; Gupta P; Gupta UD; Agrewala JN J Infect Dis; 2010 Aug; 202(3):480-9. PubMed ID: 20569158 [TBL] [Abstract][Full Text] [Related]
25. T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties. Lindenstrøm T; Moguche A; Damborg M; Agger EM; Urdahl K; Andersen P EBioMedicine; 2018 Jan; 27():27-39. PubMed ID: 29249639 [TBL] [Abstract][Full Text] [Related]
26. Acquired immunity to heavy infection with Mycobacterium bovis bacillus Calmette-Guérin and its relationship to the development of nonspecific unresponsiveness in vitro. Orme IM; Ratcliffe MJ; Collins FM Cell Immunol; 1984 Oct; 88(2):285-96. PubMed ID: 6386183 [TBL] [Abstract][Full Text] [Related]
27. Frequencies of IFN gamma- and IL-4-producing cells during Mycobacterium bovis BCG infection in two genetically susceptible mouse strains: role of alpha/beta T cells and NK1.1 cells. Teixeira HC; Munk ME; Kaufmann SH Immunol Lett; 1995 May; 46(1-2):15-9. PubMed ID: 7590911 [TBL] [Abstract][Full Text] [Related]
28. Anamnestic responses of mice following Mycobacterium tuberculosis infection. Kamath AB; Behar SM Infect Immun; 2005 Sep; 73(9):6110-8. PubMed ID: 16113332 [TBL] [Abstract][Full Text] [Related]
29. Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice. Lecoeur HF; Lagrange PH; Truffot-Pernot C; Gheorghiu M; Grosset J Clin Exp Immunol; 1989 Jun; 76(3):458-62. PubMed ID: 2502336 [TBL] [Abstract][Full Text] [Related]
30. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. Orme IM; Collins FM J Exp Med; 1983 Jul; 158(1):74-83. PubMed ID: 6602861 [TBL] [Abstract][Full Text] [Related]
31. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Flynn JL; Goldstein MM; Triebold KJ; Koller B; Bloom BR Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12013-7. PubMed ID: 1465432 [TBL] [Abstract][Full Text] [Related]
32. The effect of chemotherapy for tuberculosis on immunity to tuberculosis. Lefford MJ; McGregor DD J Infect Dis; 1974 Apr; 129(4):473-6. PubMed ID: 4206250 [No Abstract] [Full Text] [Related]
33. Study of DTH and resistance in Mycobacterium lepraemurium infection using a T-cell line isolated from mice infected with Mycobacterium bovis (BCG). Hussein S; Curtis J; Griffiths D; Turk JL Cell Immunol; 1987 Apr; 105(2):423-31. PubMed ID: 3032464 [TBL] [Abstract][Full Text] [Related]
34. Immunological consequences of innate resistance and susceptibility to BCG. Buschman E; Skamene E Immunol Lett; 1988 Nov; 19(3):199-209. PubMed ID: 3069707 [TBL] [Abstract][Full Text] [Related]
35. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination. Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC Front Immunol; 2020; 11():680. PubMed ID: 32411131 [TBL] [Abstract][Full Text] [Related]
36. Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization. Palendira U; Bean AG; Feng CG; Britton WJ Infect Immun; 2002 Mar; 70(3):1410-6. PubMed ID: 11854227 [TBL] [Abstract][Full Text] [Related]
37. T-cell-mediated immunity in persistent Mycobacterium intracellulare infections in mice. Takashima T; Collins FM Infect Immun; 1988 Nov; 56(11):2782-7. PubMed ID: 3262585 [TBL] [Abstract][Full Text] [Related]
38. Mycobacterium avium-complex infections in normal and immunodeficient mice. Collins FM; Stokes RW Tubercle; 1987 Jun; 68(2):127-36. PubMed ID: 2958962 [TBL] [Abstract][Full Text] [Related]
39. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis. Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878 [TBL] [Abstract][Full Text] [Related]
40. Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains. Bourassa D; Forget A; Pelletier M; Skamene E; Turcotte R Clin Exp Immunol; 1985 Oct; 62(1):31-8. PubMed ID: 3905097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]